Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 11/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.41 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.38 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.38 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.38 |
| ▸ | MYC | P01106 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17887119 | 1.00 | PDK2 (0.46) | PDK2MEN1KMT2ACYP19A1ADORA3 | |
| SCHEMBL19885785 | 1.00 | PDK2 (0.46) | PDK2MEN1KMT2ACYP19A1ADORA3 | |
| SCHEMBL19885772 | 1.00 | PDK2 (0.46) | PDK2MEN1KMT2ACYP19A1ADORA3 | |
| SCHEMBL17887142 | 1.00 | PDK2 (0.46) | PDK2MEN1KMT2ACYP19A1ADORA3 | |
| SCHEMBL19885802 | 0.97 | PDK2 (0.43) | PDK2MEN1KMT2ACYP19A1ADORA3 | |
| SCHEMBL17887124 | 0.97 | PDK2 (0.43) | PDK2MEN1KMT2ACYP19A1ADORA3 | |
| SCHEMBL19885777 | 0.97 | PDK2 (0.43) | PDK2MEN1KMT2ACYP19A1ADORA3 | |
| SCHEMBL23874004 | 0.96 | PDK2 (0.43) | PDK2MEN1KMT2ACYP19A1ADORA3 | |
| SCHEMBL19885801 | 0.96 | PDK2 (0.43) | PDK2MEN1KMT2ACYP19A1ADORA3 | |
| SCHEMBL17887130 | 0.96 | PDK2 (0.43) | PDK2MEN1KMT2ACYP19A1ADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200168805-A1 | ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | DOOSAN CORPORATION (KR) | 2020-05-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200168805-A1 | ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | ELOVL1, ELOVL6, ELOVL5 | PDK2 2857/4885MEN1 3738/4885KMT2A 3571/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.